Scientists have discovered a new strategy that can make pancreatic tumours visible to the immune systems of mice and vulnerable to immune attack.
List view / Grid view
Albert Einstein College of Medicine
A new study has highlighted an enzyme called ART1 as a promising target for immunity-boosting cancer treatments.
A new method, called synapse for T-cell activation (synTac), can attack HIV-infected T cells and may be a new cure for HIV and other diseases.
Oral doses of a new drug named CA administered to mouse models led to improvements in Alzheimer's disease, including memory.
Researchers have identified two molecules that explain why children experience COVID-19 differently to adults.
Drug Target Review spoke with CUE Biopharma’s President and CSO to find out how and why they created the ImmunoSTAT platform and the ways it may benefit drug design in the future.
Researchers have discovered that a signalling protein elevated in patients with AML plays a much wider role in the disease than previously thought...
CXCR7 receptor identified as a potential therapeutic target for controlling multiple sclerosis, Parkinson's and AIDS...
Scientists have discovered a compound that causes cancer cells to self-destruct while sparing healthy cells...